ArticlesRegulatory August 8, 2024 Address the complexity of protein characterization Since the FDA approved the first monoclonal based therapy in 1985, mAbs have had significant… Ross Burns
ArticlesBioPharmaRegulatory March 14, 2019 Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars Biotherapeutics are an emerging class of treatment modalities that are manufactured... admin-element